Eldridge George A's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Mar 11, 2024
- Accession no.
- 0001415889-24-007534
- Filed
- Mar 11, 2024
- Trade date
- Mar 7-11, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 4 derivative transactions. Open-market sales total $649.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eldridge George ACIK 0001413006 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | MOption exerciseAcquired | +22,386 | $2.14 | +$47,906.04 | 24,346 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −22,386 | $25.00 | −$559,650 | 1,960 | Direct | |
| Mar 8, 2024 | Common Stock | MOption exerciseAcquired | +114 | $2.14 | +$243.96 | 2,074 | Direct | |
| Mar 8, 2024 | Common Stock | SSaleDisposed | −114 | $25.00 | −$2,850 | 1,960 | Direct | |
| Mar 11, 2024 | Common Stock | MOption exerciseAcquired | +3,433 | $2.14 | +$7,346.62 | 5,393 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −3,423 | $25.24 | −$86,396.52 | 1,970 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −10 | $26.31 | −$263.1 | 1,960 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | MOption exerciseDisposed | −1,400 | $0.00 | $0 | 28,263 | Direct | |
| Mar 7, 2024 | Common Stock | MOption exerciseDisposed | −20,986 | $0.00 | $0 | 58,877 | Direct | |
| Mar 8, 2024 | Common Stock | MOption exerciseDisposed | −114 | $0.00 | $0 | 58,763 | Direct | |
| Mar 11, 2024 | Common Stock | MOption exerciseDisposed | −3,433 | $0.00 | $0 | 55,330 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.